Compare BZUN & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BZUN | STXS |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | China | United States |
| Employees | 6762 | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.5M | 164.1M |
| IPO Year | 2014 | 2004 |
| Metric | BZUN | STXS |
|---|---|---|
| Price | $2.88 | $1.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 230.1K | ★ 1.2M |
| Earning Date | 05-20-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | $7.89 | $28.22 |
| Revenue Next Year | $6.16 | $30.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.07 | $1.24 |
| 52 Week High | $4.88 | $3.59 |
| Indicator | BZUN | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 41.46 |
| Support Level | $2.61 | N/A |
| Resistance Level | $3.02 | $1.97 |
| Average True Range (ATR) | 0.12 | 0.09 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 25.44 | 50.00 |
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.